Back to Home
Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

January 22, 2026

Overview

Brain metastasis represents a significant and growing challenge in oncology, with patients often facing complex diagnostic and therapeutic hurdles. Despite recent advances, there remain unmet needs in early detection, optimal treatment selection, and coordination of multidisciplinary care.

This live, interactive symposium will feature expert-led presentations and case-based panel discussions, providing participants with the latest updates and practical strategies for managing brain metastases. The program will be held in conjunction with the 23rd Annual Winter Lung Cancer Conference, offering attendees a unique opportunity to engage with leaders in both brain metastasis and lung cancer care, and to foster collaboration across specialties dedicated to improving patient outcomes.

Learning Objectives

  • Interpret translational research advances to inform future therapeutic development and clinical decision-making in brain metastases
  • Apply recent pivotal clinical trial data and emerging systemic therapy strategies to optimize treatment sequencing for brain metastases across tumor types
  • Integrate advances in locoregional treatment modalities into evidence-based multidisciplinary management plans for patients with brain metastases

Program Chair

Manmeet Ahluwalia, MD, MBA

To view full profile, click on the Program Chair tab above.

Event Details

  • Event Date
    January 22, 2026
  • Location
    Miami Beach, FL
  • Venue
    Fontainebleau Miami Beach Florida
    4441 Collins Avenue
    Miami Beach, FL 33140
    Meeting Rooms: Glimmer 1 and 2
  • Target Audience
    This educational activity is intended towards community oncology providers, including medical oncologists, radiational oncologists, neurosurgeons, advanced practice providers, and oncology nurses who are involved in the management of CNS metastases in patients with lung cancer, breast cancer, and melanoma.

This activity is supported by an educational grant from Varian Medical Systems, Inc.

Related Content

View All